Antiphospholipid antibodies and infertility

References

• Alarcon-Segovia D, Cabral AR. The concept and classifications of antiphospholipid/cofactor syndromes. Lupus 1996; 5: 364–367
   PubMedGoogle Scholar
• American Society for Reproductive Immunology Antiphospholipid Antibody Committee. A rational basis for antiphospholipid antibody testing and selective immunotherapy in assisted reproduction: a rebuttal to the American Society for Reproductive Medicine Practice Committee opinion. Fertility and Sterility 2000; 74: 631–633
   Google Scholar
• American Society for Reproductive Medicine Practice Committee Report. Antiphospholipid antibodies do not affect IVF success. ASRM Practice Committee, ASRM. 1999
   Google Scholar
• Birdsall MA, Lockwood GM, Ledger WL, Johnson PM, Chamley LW. Antiphospholipid antibodies in women having in vitro fertilization. Human Reproduction 1996; 11: 1185–1189
   PubMed Web of Science ®Google Scholar
• Birkenfeld A, Mukaida T, Minichiello L, Jackson M, Kase NG, Yemini M. Incidence of autoimmune antibodies in failed embryo transfer cycles. American Journal of Reproductive Immunology 1994; 31: 65–68
   PubMed Web of Science ®Google Scholar
• Chilcott IT, Margara R, Cohen H, Rai R, Skull J, Pickering W, Regan L. Pregnancy outcome is not affected by antiphospholipid antibody status in women referred for in vitro fertilization. Fertility and Sterility 2000; 73: 526–530
   Google Scholar
• Coulam CB. The role of antiphospholipid antibodies in reproduction: questions answered and raised at the 18th annual meeting of the American Society of Reproductive Immunology. American Journal of Reproductive Immunology 1999; 41: 1–4
   Google Scholar
• Denis AL, Guido M, Adler RD, Bergh PA, Brenner C, Scott RT, Jr. Antiphospholipid antibodies and pregnancy rates and outcome in in vitro fertilization patients. Fertility and Sterility 1997; 67: 1084–1090
   PubMed Web of Science ®Google Scholar
• Dmowski WP, Rana N, Michalowska J, Friberg J, Papierniak C, El-Roeiy A. The effect of endometriosis, its stage and activity, and of autoantibodies on in vitro fertilization and embryo transfer success rates. Fertility and Sterility 1995; 63: 555–562
   PubMed Web of Science ®Google Scholar
• Eldar-Geva T, Wood C, Lolatgis N, Rombauts L, Kovacs G, Fuscaldo J, Trounson AO. Cumulative pregnancy and live birth rates in women with antiphospholipid antibodies undergoing assisted reproduction. Human Reproduction 1999; 14: 1461–1466
   Google Scholar
• El-Roeiy A, Gleicher N, Friberg J, Confino E, Dudkiewicz A. Correlation between peripheral blood and follicular fluid autoantibodies and impact on in vitro fertilization. Obstetrics and Gynecology 1987; 70: 163–170
   PubMed Web of Science ®Google Scholar
• Fisch B, Rikover Y, Shohat L, Zurgil N, Tadir Y, Ovadia J, Witz IP, Yron I. The relationship between in vitro fertilization and naturally occurring antibodies: evidence for increased production of antiphospholipid autoantibodies. Fertility and Sterility 1991; 56: 718–724
   PubMed Web of Science ®Google Scholar
• Fisch B, Fried S, Manor Y, Ovadia J, Witz IP, Yron I. Increased antiphospholipid antibody activity in in vitro fertilization patients is not treatment-dependent but rather an inherent characteristic of the infertile state. American Journal of Reproductive Immunology 1995; 34: 370–374
   Google Scholar
• Geva E, Yaron Y, Lessing JB, Yovel I, Vardinon N, Burke M, Amit A. Circulating autoimmune antibodies may be responsible for implantation failure in in vitro fertilization. Fertility and Sterility 1994; 62: 802–806
   PubMed Web of Science ®Google Scholar
• Gleicher N, El-Roeiy A. The reproductive autoimmune failure syndrome. American Journal of Obstetrics and Gynecology 1988; 159: 223–227
   PubMed Web of Science ®Google Scholar
• Gleicher N, El-Roeiy A, Confino E, Friberg J. Reproductive failure because of autoantibodies: unexplained infertility and pregnancy wastage. American Journal of Obstetrics and Gynecology 1989; 160: 1376–1385
   PubMed Web of Science ®Google Scholar
• Gleicher N, Liu HC, Dudkiewicz A, Rosenwaks Z, Kaberlein G, Pratt D, Karande V. Autoantibody profiles and immunoglobulin levels as predictors of in vitro fertilization success. American Journal of Obstetrics and Gynecology 1994; 170: 1145–1149
   PubMed Web of Science ®Google Scholar
• Hasegawa I, Yamanoto Y, Suzuki M, Murakawa H, Kurabayashi T, Takakuwa K, Tanaka K. Prednisolone plus low dose aspirin improves the implantation rate in women with autoimmune conditions who are undergoing in vitro fertilization. Fertility and Sterility 1998; 70: 1044–1048
   PubMed Web of Science ®Google Scholar
• Hornstein MD, Davis OK, Massey JB, Paulson RJ, Collins JA. Antiphospholipid antibodies and in vitro fertilization success: a meta-analysis. Fertility and Sterility 2000; 73: 330–333
   PubMed Web of Science ®Google Scholar
• Kaider BD, Price DE, Roussev RG, Coulam CB. Antiphospholipid antibody prevalence in patients with IVF failure. American Journal of Reproductive Immunology 1996; 35: 388–393
   PubMed Web of Science ®Google Scholar
• Kaider BD, Coulam CB, Roussev RG. Murine embryos as a direct target for some human autoantibodies in vitro. Human Reproduction 1999; 14: 2556–2561
   PubMedGoogle Scholar
• Kowalik A, Vichnin M, Liu H-C, Branch W, Berkeley AS. Midfollicular anticardiolipin and antiphosphatidylserine antibody titres do not correlate with in vitro fertilization outcome. Fertility and Sterility 1997; 68: 298–304
   PubMed Web of Science ®Google Scholar
• Kutteh WH, Yetman DL, Chantillis SJ, Crain J. Effect of antiphospholipid antibodies in women undergoing in vitro fertilization: role of heparin and aspirin. Human Reproduction 1997; 12: 1171–1175
   PubMed Web of Science ®Google Scholar
• Lee RM, Emlen W, Scott JR, Branch DW, Silver RM. Anti-β2 glycoprotein I antibodies in women with recurrent spontaneous abortion, unexplained fetal death and antiphospholipid syndrome. American Journal of Obstetrics and Gynecology 1999; 181: 642–648
   PubMedGoogle Scholar
• Lockwood CJ, Romero R, Feinberg RF, Clyne LP, Coster B, Hobbins JC. The prevalence and biological significance of lupus anticoagulant and anticardiolipin antibodies in general obstetric population. American Journal of Obstetrics and Gynecology 1989; 161: 369–373
   PubMed Web of Science ®Google Scholar
• Rai RS, Regan L, Clifford K, Pickering W, Dave M, Mackie I, McNally T, Cohen H. Antiphospholipid antibodies and beta 2-glycoprotein 1 in 500 women with recurrent miscarriage: results of a comprehensive screening approach. Human Reproduction 1995; 10: 2001–2005
   PubMed Web of Science ®Google Scholar
• Recurrent Miscarriage Immunotherapy Trialists Group. Worldwide collaborative observational study and meta-analysis on allogenic leukocyte immunotherapy for recurrent spontaneous abortion. American Journal of Reproductive Immunology 1994; 32: 55–72
   PubMed Web of Science ®Google Scholar
• Selva-O'Callaghan A, Ordi-Ros J, Monegal-Ferran F, Martinez N, Cortes-Hernandez F, Vilardell-Tarres M. IgA anticardiolipin antibodies — relation with other antiphospholipid antibodies and clinical significance. Thrombosis and Haemostasis 1998; 79: 282–285
   Google Scholar
• Sher G, Feinman M, Zouves C, Kuttner G, Maassarani G, Salem R, Matzner W, Ching W, Chong P. High fecundity rates following in vitro fertilization and embryo transfer in antiphospholipid antibody seropositive women treated with heparin and aspirin. Human Reproduction 1994; 9: 2278–2283
   PubMed Web of Science ®Google Scholar
• Sher G, Matzner W, Feinman M, Maassarani G, Zouves C, Chong P, Ching W. The selective use of heparin/aspirin therapy, alone or in combination with intravenous immunoglobulin G, in the management of antiphospholipid antibody-positive women undergoing in vitro fertilization. American Journal of Reproductive Immunology 1998; 40: 74–82
   PubMed Web of Science ®Google Scholar
• Stern C, Chamley L, Hale L, Kloss M, Speirs A, Baker HW. Antibodies to β2 glycoprotein I are associated with in vitro fertilization implantation failure as well as recurrent miscarriage: results of prevalence study. Fertility and Sterility 1998; 70: 938–944
   PubMedGoogle Scholar
• Stern CJ, Norris H, Chamley LW, Baker HWG. A randomized, double blind, placebo-controlled trial of heparin and aspirin for women with IVF-implantation failure and antiphospholipid or antinuclear antibodies. Human Reproduction 2001; 16: 74–74, (Abstract)
   Google Scholar
• Sthoeger ZM, Mozes E, Tartakovsky B. Anti-cardiolipin antibodies induce pregnancy failure by impairing embryonic implantation. Proceedings National Academy of Sciences USA 1993; 90: 6464–6467
   PubMed Web of Science ®Google Scholar
• Tartakovsky B, Bermas BL, Sthoeger Z, Shearer GM, Mozes E. Defective maternal-fetal interaction in a murine autoimmune model. Human Reproduction 1996; 11: 2408–2411
   PubMed Web of Science ®Google Scholar
• Taylor PV, Campbell JM, Scott JS. Presence of autoantibodies in women with unexplained infertility. American Journal of Obstetrics and Gynecology 1989; 161: 377–379
   PubMed Web of Science ®Google Scholar
• Wilson, WA, Gharavi, AE, Koike, T, et al. International consensus statement on preliminary classification criteria for definite antiphospholipid syndrome. Report of an international workshop. Arthritis and Rheumatism 1999; 42: 1309–1311
   PubMed Web of Science ®Google Scholar